No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening

Brianna L. Norton, William N. Southern, Meredith Steinman, Bryce D. Smith, Joseph P. DeLuca, Zachary Rosner, Alain H. Litwin

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background & Aims National hepatitis C virus (HCV) screening guidelines recommended 1-time testing of persons born between 1945 and 1965. Methods We performed a retrospective study to compare care milestones achieved by HCV-infected patients identified by birth cohort versus risk-based screens. Results We determined the proportions of patients newly identified with HCV infection who met care milestones (viral load, referral to and evaluation by a specialist, offer of treatment, initiation of treatment, and sustained viral response) and the time it took to reach them. We found no differences in HCV care milestones for patients identified via birth cohort testing versus risk-based screening. Overall, only 43% of HCV antibody-positive patients were referred to care, and less than 4% started treatment. The time to each care milestone was lengthy and varied greatly; treatment was initiated in a median of 308 days. Conclusions Although birth cohort testing will likely increase identification of patients with HCV infection, it does not seem to increase the number of patients that meet management milestones. New methods are needed to increase access to care and establish efficient models of health care delivery.

Original languageEnglish (US)
Pages (from-to)1356-1360
Number of pages5
JournalClinical Gastroenterology and Hepatology
Volume14
Issue number9
DOIs
StatePublished - 2016

Fingerprint

Hepacivirus
Patient Care
Parturition
Virus Diseases
Hepatitis C Antibodies
Therapeutics
Viral Load
Reaction Time
Referral and Consultation
Retrospective Studies
Guidelines
Delivery of Health Care

Keywords

  • Antiviral Agent
  • Cascade of Care
  • Patient Management
  • Population
  • Therapy

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening. / Norton, Brianna L.; Southern, William N.; Steinman, Meredith; Smith, Bryce D.; DeLuca, Joseph P.; Rosner, Zachary; Litwin, Alain H.

In: Clinical Gastroenterology and Hepatology, Vol. 14, No. 9, 2016, p. 1356-1360.

Research output: Contribution to journalArticle

@article{c1a349f497e7475581b0d3c2faa745c8,
title = "No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening",
abstract = "Background & Aims National hepatitis C virus (HCV) screening guidelines recommended 1-time testing of persons born between 1945 and 1965. Methods We performed a retrospective study to compare care milestones achieved by HCV-infected patients identified by birth cohort versus risk-based screens. Results We determined the proportions of patients newly identified with HCV infection who met care milestones (viral load, referral to and evaluation by a specialist, offer of treatment, initiation of treatment, and sustained viral response) and the time it took to reach them. We found no differences in HCV care milestones for patients identified via birth cohort testing versus risk-based screening. Overall, only 43{\%} of HCV antibody-positive patients were referred to care, and less than 4{\%} started treatment. The time to each care milestone was lengthy and varied greatly; treatment was initiated in a median of 308 days. Conclusions Although birth cohort testing will likely increase identification of patients with HCV infection, it does not seem to increase the number of patients that meet management milestones. New methods are needed to increase access to care and establish efficient models of health care delivery.",
keywords = "Antiviral Agent, Cascade of Care, Patient Management, Population, Therapy",
author = "Norton, {Brianna L.} and Southern, {William N.} and Meredith Steinman and Smith, {Bryce D.} and DeLuca, {Joseph P.} and Zachary Rosner and Litwin, {Alain H.}",
year = "2016",
doi = "10.1016/j.cgh.2016.04.017",
language = "English (US)",
volume = "14",
pages = "1356--1360",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening

AU - Norton, Brianna L.

AU - Southern, William N.

AU - Steinman, Meredith

AU - Smith, Bryce D.

AU - DeLuca, Joseph P.

AU - Rosner, Zachary

AU - Litwin, Alain H.

PY - 2016

Y1 - 2016

N2 - Background & Aims National hepatitis C virus (HCV) screening guidelines recommended 1-time testing of persons born between 1945 and 1965. Methods We performed a retrospective study to compare care milestones achieved by HCV-infected patients identified by birth cohort versus risk-based screens. Results We determined the proportions of patients newly identified with HCV infection who met care milestones (viral load, referral to and evaluation by a specialist, offer of treatment, initiation of treatment, and sustained viral response) and the time it took to reach them. We found no differences in HCV care milestones for patients identified via birth cohort testing versus risk-based screening. Overall, only 43% of HCV antibody-positive patients were referred to care, and less than 4% started treatment. The time to each care milestone was lengthy and varied greatly; treatment was initiated in a median of 308 days. Conclusions Although birth cohort testing will likely increase identification of patients with HCV infection, it does not seem to increase the number of patients that meet management milestones. New methods are needed to increase access to care and establish efficient models of health care delivery.

AB - Background & Aims National hepatitis C virus (HCV) screening guidelines recommended 1-time testing of persons born between 1945 and 1965. Methods We performed a retrospective study to compare care milestones achieved by HCV-infected patients identified by birth cohort versus risk-based screens. Results We determined the proportions of patients newly identified with HCV infection who met care milestones (viral load, referral to and evaluation by a specialist, offer of treatment, initiation of treatment, and sustained viral response) and the time it took to reach them. We found no differences in HCV care milestones for patients identified via birth cohort testing versus risk-based screening. Overall, only 43% of HCV antibody-positive patients were referred to care, and less than 4% started treatment. The time to each care milestone was lengthy and varied greatly; treatment was initiated in a median of 308 days. Conclusions Although birth cohort testing will likely increase identification of patients with HCV infection, it does not seem to increase the number of patients that meet management milestones. New methods are needed to increase access to care and establish efficient models of health care delivery.

KW - Antiviral Agent

KW - Cascade of Care

KW - Patient Management

KW - Population

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84997112319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997112319&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2016.04.017

DO - 10.1016/j.cgh.2016.04.017

M3 - Article

VL - 14

SP - 1356

EP - 1360

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 9

ER -